KDventures AB

kr 0.14As of Sun 8 Nov 2026, 12:00 UTC
STO:KDV-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (28.37%)
Div yield —
ROE (64.73%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.59
PE TTM —
TSR TTM (80.35%)
Mkt cap kr 106.2M
ROIC (1.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.165
17.85%
(88.79%)
Buy 10|6|5|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
—
—
—
10.96%
6.56%
18.39%
18.42%
Revenuekr M
6.059
6.168
6.520
6.601
7.03%
5.80%
7.64%
5.76%
Peers (US$10.74M)
Cap (US$)
PE
11.93M
—
10.99M
—
8.788M
—
Capital
TTM
5Y
10Y
Leveragex
1.001
0.064
0.062
EBIT/Intx
1.634
0.778
0.693
Own earn%
62.30
(9.33)
—
Sh yield%
27.36
62.58
62.62
Owners
Insiders/Inst%
6.60
74.42
Short interest%
3.12
SBC / revenue%
1.39
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
8–13
$1 testx
—
Incr. ROIC%
10